The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling

AIMS: Although clinical guidelines advocate the use of the highest tolerated dose of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers after acute myocardial infarction (MI), the optimal dosing or the risk–benefit profile of different doses have not been fully identified. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kyungil, Kim, Young‐Dae, Kim, Ki‐Sik, Lee, Su‐Hoon, Park, Tae‐Ho, Lee, Sang‐Gon, Kim, Byung‐Soo, Hur, Seung‐Ho, Yang, Tae‐Hyun, Oh, Joo‐Hyun, Hong, Taek‐Jong, Park, Jong‐Sun, Hwang, Jin‐Yong, Jeong, Byungcheon, Bae, Woo‐Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880661/
https://www.ncbi.nlm.nih.gov/pubmed/29341471
http://dx.doi.org/10.1002/ehf2.12249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880661/
https://www.ncbi.nlm.nih.gov/pubmed/29341471
http://dx.doi.org/10.1002/ehf2.12249

Ejemplares similares